Dark
Light
System
Security
Carbylan Therapeutics Inc.
Carbylan Therapeutics Inc.. Institutional holdings reported to the SEC.

Institutional Holders (2016Q3)
Portfolio Summary: 21 Institutional holders with a total value of $2,628,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 VIVO CAPITAL, LLC 4,204,562 1,934,000 73.59%
2 VANGUARD GROUP INC 426,668 196,000 7.46%
3 RENAISSANCE TECHNOLOGIES LLC 242,721 112,000 4.26%
4 FIRST QUADRANT LLC/CA 178,500 82,000 3.12%
5 Alyeska Investment Group, L.P. 161,246 74,000 2.82%
6 ALBION FINANCIAL GROUP /UT 96,954 45,000 1.71%
7 DEUTSCHE BANK AG\ 96,123 44,000 1.67%
8 GOLDMAN SACHS GROUP INC 95,478 44,000 1.67%
9 GEODE CAPITAL MANAGEMENT, LLC 67,118 30,000 1.14%
10 BlackRock Fund Advisors 24,645 11,000 0.42%
11 WEDBUSH SECURITIES INC 21,700 10,000 0.38%
12 Virtu KCG Holdings LLC 21,478 10,000 0.38%
13 NORTHERN TRUST CORP 20,537 9,000 0.34%
14 UBS Group AG 16,716 8,000 0.30%
15 Bank of New York Mellon Corp 14,255 7,000 0.27%
16 Tower Research Capital LLC (TRC) 10,492 5,000 0.19%
17 BLACKROCK ADVISORS LLC 3,615 2,000 0.08%
18 MANUFACTURERS LIFE INSURANCE COMPANY, THE 4,366 2,000 0.08%
19 BlackRock Institutional Trust Company, N.A. 5,075 2,000 0.08%
20 MORGAN STANLEY 2,813 1,000 0.04%
21 BANK OF AMERICA CORP /DE/ 823 0 0.00%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.